We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Biomarker Identified for Predicting Increased Risk of Developing Posttraumatic Epilepsy

By HospiMedica International staff writers
Posted on 05 Jan 2011
The analysis of conventional magnetic resonance imaging (MRI) scans can effectively quantify the disruptions in the blood brain barrier that are increasingly thought to be a prominent contributor to epilepsy development.

About 5%-30% of patients with traumatic brain injury (TBI) develop post-traumatic epilepsy (PTE). More...
The onset of seizures in patients who are susceptible to PTE can range from weeks or months to more than a decade after TBI. In a presentation December 7, 2010, researchers presented their findings at the 64th American Epilepsy Society annual meeting, held San Antonio, TX, USA.

Investigators from the University of Colorado (Boulder, USA) used MRI imaging to distinguish between brain injured and sham injured laboratory animals. At three months post-injury, the animals were administered a substance known to provoke seizures. The investigators found that the level of blood brain barrier disruption observed in the images was considerably correlated with the total number of seizures occurring in the first 60 minutes after the substance was administered, as well as correlating with how soon after drug administration the seizures began.

According to Dr. Lauren Frey, lead author of the report, "The significant correlation we found between the images and post-injury seizure susceptibility supports the presence of blood brain barrier disruption as a biomarker for posttraumatic epileptogenesis.”

A biomarker that identifies brain-injured patients at risk of developing PTE could help in research aimed at finding a preventive therapy; and, once such a therapy is available, aid in selecting at-risk patients for preventive care.

Related Links:
University of Colorado


New
Gold Member
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Fetal Monitor
BT-380
New
Gold Member
Radiology Monitor
MDNC-12130 Barco Nio Fusion 12MP
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Cedit: Shutterstock

New Light-Activated Platform Advances Glioblastoma Surgery and Postoperative Treatment

Glioblastoma, an aggressive primary brain tumor, infiltrates healthy tissue and resists complete surgical removal. Residual microscopic disease and the blood–brain barrier limit the effectiveness of adjuvant... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.